Catalent, Inc. (CTLT) financial statements (2020 and earlier)

Company profile

Business Address 14 SCHOOLHOUSE ROAD
SOMERSET, NJ 08873
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments24334541030713215174
Cash and cash equivalents24334541028813215174
Short-term investments   19   
Receivables648716556489415372404
Inventory, net of allowances, customer advances and progress billings251257209185155133135
Inventory251257209185155133135
Prepaid expense41191924292217
Contract with customer, asset16 
Deferred tax assets    2013
Other current assets25241544422833
Other undisclosed current assets42353112181213
Total current assets:1,2671,3961,2401,060790738688
Noncurrent Assets
Property, plant and equipment1,5611,5371,271996906885873
Intangible assets, net (including goodwill)3,0993,1521,9421,3171,2911,4301,455
Goodwill2,1962,2211,3971,0449971,0621,097
Intangible assets, net (excluding goodwill)903931545273294369358
Regulated entity, other noncurrent assets   12 1020
Deferred costs   15 1020
Other noncurrent assets159614528672849
Other undisclosed noncurrent assets343933273845(13)
Total noncurrent assets:4,8534,7883,2912,3952,3012,4082,403
TOTAL ASSETS:6,1206,1844,5313,4543,0913,1453,090
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities542594505444364519588
Accounts payable214256192163144128148
Accrued liabilities328338313281220247280
Employee-related liabilities     8887
Taxes payable     5662
Interest and dividends payable     012
Debt74777225282425
Deferred revenue and credits   3947
Deferred tax liabilities    21
Other liabilities     5561
Other undisclosed current liabilities     (240)(269)
Total current liabilities:616671577469391399453
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,8592,8832,6492,0551,8331,8642,685
Finance lease, liability157
Operating lease, liability57
Other undisclosed long-term debt and lease obligation2,6452,8832,6492,0551,8331,8642,685
Liabilities, other than long-term debt319268186175190186216
Liability, pension and other postretirement and postemployment benefits140144132130151144155
Other liabilities1791245446394361
Other undisclosed noncurrent liabilities717433324156103
Total noncurrent liabilities:3,2483,2252,8682,2622,0642,1073,005
Total liabilities:3,8643,8963,4442,7312,4552,5063,458
Temporary equity, carrying amount607    65
Stockholders' equity
Stockholders' equity attributable to parent, including:1,6491,6821,087724636634(371)
Preferred stock00     
Common stock    111
Additional paid in capital2,7552,7572,2831,9921,9771,9741,031
Accumulated other comprehensive loss(376)(354)(326)(314)(306)(174)(24)
Accumulated deficit(731)(723)(872)(956)(1,036)(1,167)(1,379)
Other undisclosed stockholders' equity attributable to parent1111   
Stockholders' equity attributable to noncontrolling interest      (1)
Total stockholders' equity:1,6491,6821,087724636634(372)
Other undisclosed liabilities and equity 607     
TOTAL LIABILITIES AND EQUITY:6,1206,1844,5313,4543,0913,1453,090

Income statement (P&L) ($ in millions)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenues2,6312,5182,4632,0751,8481,8311,828
Revenue, net2,4632,0751,8481,8311,828
Cost of revenue
(Cost of Goods and Services Sold)
(1,797)(1,713)(1,711)(1,421)(1,261)(1,225)(1,239)
Other undisclosed gross profit     1010
Gross profit:834805753655588615599
Operating expenses(544)(526)(473)(411)(367)(498)(498)
Other operating expense, net
(Other Nonrecurring (Income) Expense)
     (42)(10)
Other undisclosed operating income (loss)(2)(5)(9)(10)(3)185151
Operating income:288274271234218260241
Nonoperating income (expense)(2)(3)(8)(9)16(42)7
Investment income, nonoperating208(12)(21) 48 
Loss on contract termination     (30) 
Foreign currency transaction gain (loss), before tax113(8) 1617
Other nonoperating income (expense)513(1) 3(2)(10)
Interest and debt expense2(4)(3)(2)(2)(2)(10)
Other undisclosed loss from continuing operations before equity method investments, income taxes(121)(107)(109)(88)(87)(103)(170)
Income from continuing operations before income taxes:16716015213614511367
Income tax expense (benefit)(15)(23)(68)(26)(34)98(50)
Income from continuing operations:1521378411011121018
Income (loss) from discontinued operations     0(3)
Net income:1521378411011121015
Net income attributable to noncontrolling interest    021
Net income attributable to parent:1521378411011221216
Other undisclosed net loss available to common stockholders, basic(14)(5)     
Net income available to common stockholders, diluted:1381328411011221216

Comprehensive Income ($ in millions)

9/30/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net income:1521378411011121015
Other comprehensive income (loss)(42)(28)(12)(8)(132)(150)19
Comprehensive income (loss):11010972101(21)6134
Comprehensive income, net of tax, attributable to noncontrolling interest    021
Comprehensive income (loss), net of tax, attributable to parent:11010972101(20)6234

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: